Das Pyhrn-Eisenwurzen Klinikum Steyr ist ein großes Krankenhaus der Oberösterreichischen Gesundheitsholding in der Statutarstadt Steyr. Ein weiterer Standort befindet sich in Kirchdorf an der Krems. Das alte Hauptgebäude in Steyr steht unter Denkmalschutz.

During the past decade, Oö. Gesundheits- und Spitals-AG/LKH Steyr conducted 16 clinical trials. In the 10-year time frame, 16 clinical trials started and 6 clinical trials were completed, i.e. on average, 37.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Oö. Gesundheits- und Spitals-AG/LKH Steyr" #1 sponsor was "Allergan" with 4 trials, followed by "Austrian Breast & Colorectal Cancer Study Group" with 3 trials sponsored, "Hoffmann-La Roche" with 3 trials sponsored, "Amgen" with 2 trials sponsored and "Celgene" with 2 trials sponsored. Other sponsors include 2 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oö. Gesundheits- und Spitals-AG/LKH Steyr" #1 collaborator was "AstraZeneca" with 2 trials as a collaborator, "Novartis Pharmaceuticals" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Breast International Group" with 1 trials as a collaborator and "ETOP IBCSG Partners Foundation" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Oö. Gesundheits- und Spitals-AG/LKH Steyr" are "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Breast Cancer" (2 trials), "Colorectal Cancer" (2 trials) and "Metastatic Breast Cancer" (2 trials). Many other conditions were trialed in "Oö. Gesundheits- und Spitals-AG/LKH Steyr" in a lesser frequency.

Most popular intervention types in "Oö. Gesundheits- und Spitals-AG/LKH Steyr" are "Drug" (18 trials), "Biological" (2 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Capecitabine" (3 trials), "Gemcitabine" (3 trials), "Relamorelin" (3 trials) and "Fulvestrant" (2 trials). Other intervention names were less common.

The vast majority of trials in "Oö. Gesundheits- und Spitals-AG/LKH Steyr" are 18 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "Oö. Gesundheits- und Spitals-AG/LKH Steyr". undefined are not yet recruiting, 6 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in Oö. Gesundheits- und Spitals-AG/LKH Steyr, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Oö. Gesundheits- und Spitals-AG/LKH Steyr, 1 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".